Eczematous Dermatoses

  • Alberto Rosenblatt
  • Homero Gustavo de Campos Guidi
  • Walter BeldaJr.
Chapter

Abstract

Dermatitis is an inflammation of the skin, often caused by an irritating substance or a contact allergy, which usually manifests as an itchy rash. Atopic dermatitis refers to a subgroup of inflammatory skin condition characterized by a chronic and relapsing course associated with epidermal barrier dysfunction. In this chapter, the eczematous disorders that can affect the male genital region are discussed

Keywords

Atopic Dermatitis Contact Dermatitis Allergic Contact Dermatitis Lichen Planus Atopic Dermatitis Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aschoff R, Wozel G (2007) Topical tacrolimus for the treatment of lichen simplex chronicus. J Dermatol Treat 18:115–117CrossRefGoogle Scholar
  2. Bauer A, Geier J, Elsner P (2000) Allergic contact dermatitis in patients with anogenital complaints. J Reprod Med 45:649–654PubMedGoogle Scholar
  3. Bhate K, Landeck L, Gonzalez E, Neumann K, Schalock PC (2010) Genital contact dermatitis: a retrospective analysis. Dermatitis 21:317–320PubMedGoogle Scholar
  4. Bircher AJ, Hirsbrunner P, Langauer S (1993) Allergic contact dermatitis of the genitals from rubber additives in condoms. Contact Dermatitis 28:125–126PubMedCrossRefGoogle Scholar
  5. Birley HD, Walker MM, Luzzi GA, Bell R, Taylor-Robinson D, Byrne M, Renton AM (1993) Clinical features and management of recurrent balanitis; association with atopy and genital washing. Genitourin Med 69:400–403PubMedGoogle Scholar
  6. Brahimi N, Routier E, Raison-Peyron N, Tronquoy AF, Pouget-Jasson C, Amarger S, Machet L, Amsler E, Claeys A, Sassolas B, Leroy D, Grange A, Dupuy A, Cordel N, Bonnetblanc JM, Milpied B, Doutre MS, Guinnepain MT, Barbaud A, Chosidow O, Roujeau JC, Lebrun-Vignes B, Descamps V (2010) A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol 20:461–464PubMedGoogle Scholar
  7. Czelusta AJ, Evans T, Arany I, Tyring SK (1999) A guide to immunotherapy of genital warts: focus on interferon and imiquimod. BioDrugs 11:319–332PubMedCrossRefGoogle Scholar
  8. Diamantis ML, Bartlett BL, Tyring SK (2009) Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts. Skin Therapy Lett 14(1–3):5Google Scholar
  9. Fisher AA (1994) Allergic contact dermatitis to nonoxynol-9 in a condom. Cutis 53:110–111PubMedGoogle Scholar
  10. Friedmann PS (1990) The immunology of allergic contact dermatitis: the DNCB story. Adv Dermatol 5:175–195;discussion 196PubMedGoogle Scholar
  11. Fuchs M, Schliemann-Willers S, Heinemann C, Elsner P (2002) Tacrolimus enhances irritation in a 5-day human irritancy in vivo model. Contact Dermatitis 46:290–294PubMedCrossRefGoogle Scholar
  12. Garcia JC, Torre F, Sanchez M, Martin JA, Canto G (1997) Fixed drug eruption induced by lidocaine and patch testing. J Investig Allergol Clin Immunol 7:127–128PubMedGoogle Scholar
  13. Garcia Ortiz JC, Moyano JC, Alvarez M, Bellido J (1998) Latex allergy in fruit-allergic patients. Allergy 53:532–536PubMedCrossRefGoogle Scholar
  14. Gell P, Coombs R (1963) Clinical aspects of immunology. Blackwell, OxfordGoogle Scholar
  15. Grossberg AL, Gaspari AA (2011) Topical antineoplastic agents in the treatment of mucocutaneous diseases. Curr Probl Dermatol 40:71–82PubMedCrossRefGoogle Scholar
  16. Hauser W (1980) Lokalisationsproblem bei hautkrank­heiten. In: Korting GW (ed) Dermatologie in praxis und klinik. Thieme, Stuttgart, pp 8.60–8.93Google Scholar
  17. Heratizadeh A, Werfel T, Kapp A (2006) Atopic dermatitis: the hygiene hypothesis: prevention through helminth infections? Hautarzt 57(576):578–585Google Scholar
  18. Hoare C, Li Wan Po A, Williams H (2000) Systematic review of treatments for atopic eczema. Health Technol Assess 4:1–191PubMedGoogle Scholar
  19. Hvid M, Vestergaard C, Kemp K, Christensen GB, Deleuran B, Deleuran M (2011) IL-25 in atopic ­dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 131:150–157PubMedCrossRefGoogle Scholar
  20. Jacob SE, Steele T (2006) Allergic contact dermatitis: early recognition and diagnosis of important allergens. Dermatol Nurs 18(433–439):446Google Scholar
  21. Jansen CT, Haapalahti J, Hopsu-Havu VK (1973) Immunoglobulin E in the human atopic skin. Arch Dermatol Forsch 246:209–302PubMedGoogle Scholar
  22. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004 May;113(5):832–6Google Scholar
  23. Kauppinen K, Kariniemi A-L (1998) Clinical manifestations and histological characteristics. In: Kauppinen K, Alanko K, Hannukelsa M (eds) Skin reactions to drugs. CRC Press, Boca Raton, pp 30–31Google Scholar
  24. Korkij W, Soltani K (1984) Fixed drug eruption. A brief review. Arch Dermatol 120:520–524PubMedCrossRefGoogle Scholar
  25. Kugler K, Brinkmeier T, Frosch PJ, Uter W (2005) Anogenital dermatoses–allergic and irritative causative factors. Analysis of IVDK data and review of the literature. J Dtsch Dermatol Ges 3:979–986PubMedCrossRefGoogle Scholar
  26. Lee JY, Wang BJ (1995) Contact dermatitis caused by cetrimide in antiseptics. Contact Dermatitis 33:168–171PubMedCrossRefGoogle Scholar
  27. Lotti T, Buggiani G, Prignano F (2008) Prurigo nodularis and lichen simplex chronicus. Dermatol Ther 21:42–46PubMedCrossRefGoogle Scholar
  28. Lynch PJ (2004) Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther 17:8–19PubMedCrossRefGoogle Scholar
  29. McNally NJ, Phillips DR, Williams HC (1998) The problem of atopic eczema: aetiological clues from the environment and lifestyles. Soc Sci Med 46:729–741PubMedCrossRefGoogle Scholar
  30. Mizukawa Y, Shiohara T (2002) Trauma-localized fixed drug eruption: involvement of burn scars, insect bites and venipuncture sites. Dermatology 205:159–161PubMedCrossRefGoogle Scholar
  31. Mizukawa Y, Shiohara T (2009) Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Curr Allergy Asthma Rep 9:71–77PubMedCrossRefGoogle Scholar
  32. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357PubMedGoogle Scholar
  33. Nnoruka EN, Ikeh VO, Mbah AU (2006) Fixed drug eruption in Nigeria. Int J Dermatol 45:1062–1065PubMedCrossRefGoogle Scholar
  34. Nussinovitch M, Prais D, Ben-Amitai D, Amir J, Volovitz B (2002) Fixed drug eruption in the genital area in 15 boys. Pediatr Dermatol 19:216–219PubMedCrossRefGoogle Scholar
  35. Ogawa M, Berger PA, McIntyre OR, Clendenning WE, Ishizaka K (1971) IgE in atopic dermatitis. Arch Dermatol 103:575–580PubMedCrossRefGoogle Scholar
  36. Ozkaya E (2007) Fixed drug eruption: primary site involvement on maximal points of Head’s zones. Acta Derm Venereol 87:517–520PubMedCrossRefGoogle Scholar
  37. Ozkaya-Bayazit E (2003) Specific site involvement in fixed drug eruption. J Am Acad Dermatol 49:1003–1007PubMedCrossRefGoogle Scholar
  38. Prud’homme GJ (1995) Immune-mediated tissue injury (hypersensitivity reactions). In: McGill journal of medicine, vol 1. McGill University, MontrealGoogle Scholar
  39. Rajalakshmi R, Thappa DM, Jaisankar TJ, Nath AK (2011) Lichen simplex chronicus of anogenital region: a clinico-etiological study. Indian J Dermatol Venereol Leprol 77:28–36PubMedCrossRefGoogle Scholar
  40. Roddy RE, Cordero M, Cordero C, Fortney JA (1993) A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 4:165–170PubMedGoogle Scholar
  41. Rosenblatt A, de Campos Guidi HG (2009) Human papillomavirus and external genital lesions. In: Rosenblatt A, de Campos Guidi HG (eds) Human papillomavirus – a practical guide for urologists. Springer, Heidelberg, pp 52–71Google Scholar
  42. Sharma VK, Dhar S, Gill AN (1996) Drug related involvement of specific sites in fixed eruptions: a statistical evaluation. J Dermatol 23:530–534PubMedGoogle Scholar
  43. Singh G (1973) Atopy in lichen simplex (neurodermatitis circumscripta). Br J Dermatol 89:625–627PubMedCrossRefGoogle Scholar
  44. Sonnex C (2004) Genital allergy. Sex Transm Infect 80:4–7PubMedCrossRefGoogle Scholar
  45. Sussman GL, Beezhold DH (1995) Allergy to latex rubber. Ann Intern Med 122:43–46PubMedGoogle Scholar
  46. Tatti S, Stockfleth E, Beutner KR, Tawfik H, Elsasser U, Weyrauch P, Mescheder A (2010) Polyphenon E: a new treatment for external anogenital warts. Br J Dermatol 162:176–184PubMedCrossRefGoogle Scholar
  47. Thankappan TP, Zachariah J (1991) Drug-specific clinical pattern in fixed drug eruptions. Int J Dermatol 30:867–870PubMedCrossRefGoogle Scholar
  48. Wakelin SH, White IR (1999) Natural rubber latex allergy. Clin Exp Dermatol 24:245–248PubMedCrossRefGoogle Scholar
  49. Warshaw EM, Furda LM, Maibach HI, Rietschel RL, Fowler JF Jr, Belsito DV, Zug KA, DeLeo VA, Marks JG Jr, Mathias CG, Pratt MD, Sasseville D, Storrs FJ, Taylor JS (2008) Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994–2004. Arch Dermatol 144:749–755PubMedCrossRefGoogle Scholar
  50. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, Klopp N, Wagenpfeil S, Zhao Y, Liao H, Lee SP, Palmer CN, Jenneck C, Maintz L, Hagemann T, Behrendt H, Ring J, Nothen MM, McLean WH, Novak N (2006) Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118:214–219PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Alberto Rosenblatt
    • 1
  • Homero Gustavo de Campos Guidi
    • 2
  • Walter BeldaJr.
    • 3
  1. 1.Albert Einstein Jewish Hospital (HIAE)São PauloBrazil
  2. 2.University of São Paulo Medical SchoolSão PauloBrazil
  3. 3.Department of DermatologyUniversity of São Paulo Medical SchoolSão PauloBrazil

Personalised recommendations